CASP8 and non-small cell lung carcinoma: Entinostat is also an HDACi; McLaughlin et al. found that, in a model of NSCLC, entinostat could sensitize a proportion of NSCLC cells to IR by effectively down-regulating FLIP expression and the capacity to boost caspase-8 activation [144].